Forward-thinking employers use Health Savings Accounts (HSAs) to invest in meaningful wellness benefits including proactive cancer risk assessment through miRoncol.
Cancer remains the leading cause of lost productivity and medical cost in the workplace. Yet, most cancers are still detected only after symptoms appear.
By integrating miRoncol’s Real-time Multi-Cancer Early Risk Assessment into your company’s wellness program, you can help employees take a proactive step in understanding their current biological cancer risk — using funds already available in their HSA accounts.
Offering preventive tools like miRoncol demonstrates a tangible commitment to employee well-being and long-term health.
KEY BENEFITS:
Employees can use HSA funds for the miRoncol Early Risk Assessment, reinforcing your company’s prevention-first culture.
Helps employees detect cancer-like molecular signals sooner, leading to more timely medical evaluation.
Encourages evidence-based health discussions between staff and their physicians.
Wellness benefits that go beyond gym memberships and routine check-ups resonate with a modern, proactive workforce.
The miRoncol test provides a blood-based early cancer risk assessment identifying molecular signals associated with common solid tumours such as lung, breast, prostate, colorectal, and pancreatic cancers.
Early detection is no longer limited to hospital-based screening. As precision medicine moves into preventive health, molecular pre-screening tools like miRoncol help close the gap between prevention and diagnosis.
By encouraging your employees to participate, your organization becomes part of the shift toward real-time, proactive health monitoring where prevention is an act of empowerment.
If you manage health benefits or oversee an employee wellness program: